Wang et al., 2013 - Google Patents
Significance of glycosylphosphatidylinositol-anchored protein enrichment in lipid rafts for the control of autoimmunityWang et al., 2013
View HTML- Document ID
- 4761367154740332167
- Author
- Wang Y
- Murakami Y
- Yasui T
- Wakana S
- Kikutani H
- Kinoshita T
- Maeda Y
- Publication year
- Publication venue
- Journal of Biological Chemistry
External Links
Snippet
Glycosylphosphatidylinositols (GPI) are complex glycolipids that are covalently linked to the C terminus of proteins as a post-translational modification and tether proteins to the plasma membrane. One of the most striking features of GPI-anchored proteins (APs) is their …
- 150000002632 lipids 0 title abstract description 59
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | Significance of glycosylphosphatidylinositol-anchored protein enrichment in lipid rafts for the control of autoimmunity | |
| Anzilotti et al. | An essential role for the Zn2+ transporter ZIP7 in B cell development | |
| Chen et al. | Broad and direct interaction between TLR and Siglec families of pattern recognition receptors and its regulation by Neu1 | |
| Ding et al. | Integrin CD11b negatively regulates BCR signalling to maintain autoreactive B cell tolerance | |
| Rosenbaum et al. | MZB1 is a GRP94 cochaperone that enables proper immunoglobulin heavy chain biosynthesis upon ER stress | |
| Sisirak et al. | Digestion of chromatin in apoptotic cell microparticles prevents autoimmunity | |
| Yang et al. | CLEC4F is an inducible C-type lectin in F4/80-positive cells and is involved in alpha-galactosylceramide presentation in liver | |
| Lesage et al. | Failure to censor forbidden clones of CD4 T cells in autoimmune diabetes | |
| Hu et al. | XBP‐1 regulates signal transduction, transcription factors and bone marrow colonization in B cells | |
| Okazaki et al. | PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice | |
| Yim et al. | Role of Selenof as a gatekeeper of secreted disulfide-rich glycoproteins | |
| Liston et al. | Gene dosage–limiting role of Aire in thymic expression, clonal deletion, and organ-specific autoimmunity | |
| Arnold et al. | A forward genetic screen reveals roles for Nfkbid, Zeb1, and Ruvbl2 in humoral immunity | |
| Savitsky et al. | B-1 B lymphocytes require Blimp-1 for immunoglobulin secretion | |
| Gülden et al. | Toll-like receptor 4 deficiency accelerates the development of insulin-deficient diabetes in non-obese diabetic mice | |
| Azuma et al. | Potential role of decoy B7-H4 in the pathogenesis of rheumatoid arthritis: a mouse model informed by clinical data | |
| Yi et al. | The adaptor TRAF3 restrains the lineage determination of thymic regulatory T cells by modulating signaling via the receptor for IL-2 | |
| Bondanza et al. | Requirement of dying cells and environmental adjuvants for the induction of autoimmunity | |
| Claes et al. | The P522R protective variant of PLCG2 promotes the expression of antigen presentation genes by human microglia in an Alzheimer's disease mouse model | |
| Pupovac et al. | Activation of the P2X7 receptor induces the rapid shedding of CD23 from human and murine B cells | |
| Ossart et al. | Breakdown of immune tolerance in AIRE-deficient rats induces a severe autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy–like autoimmune disease | |
| Dong et al. | CD4+ T-cell dysfunctions through the impaired lipid rafts ameliorate concanavalin A-induced hepatitis in sphingomyelin synthase 1-knockout mice | |
| Boettcher et al. | Porcine signal regulatory protein alpha binds to human CD47 to inhibit phagocytosis: Implications for human hematopoietic stem cell transplantation into severe combined immunodeficient pigs | |
| Lu et al. | Inactivation of NuRD component Mta2 causes abnormal T cell activation and lupus-like autoimmune disease in mice | |
| Mihailovic et al. | The cathelicidin protein CRAMP is a potential atherosclerosis self-antigen in ApoE (-/-) mice |